Clinical Trial Update: The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of HIPEC combined with a PD-1 inhibitor and S-1 plus oxaliplatin chemotherapy in metastatic gastric cancer or e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Junction Cancer
• Gastric Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• Pembrolizumab (pembrolizumab)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Gastric Cancer, Metastatic | Phase 2 | Status: ACTIVE_NOT_RECRUITING